KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 131 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $965,000 | -8.1% | 256,725 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $1,050,000 | -12.1% | 256,725 | 0.0% | 0.01% | -12.5% |
Q4 2017 | $1,194,000 | -34.5% | 256,725 | 0.0% | 0.01% | -33.3% |
Q3 2017 | $1,823,000 | -1.8% | 256,725 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $1,856,000 | +17.4% | 256,725 | 0.0% | 0.01% | +20.0% |
Q1 2017 | $1,581,000 | +5.1% | 256,725 | 0.0% | 0.01% | 0.0% |
Q4 2016 | $1,504,000 | -10.8% | 256,725 | -19.2% | 0.01% | -9.1% |
Q3 2016 | $1,687,000 | -43.6% | 317,725 | -29.7% | 0.01% | -45.0% |
Q2 2016 | $2,990,000 | +41.7% | 451,725 | 0.0% | 0.02% | +53.8% |
Q1 2016 | $2,110,000 | +22.2% | 451,725 | +32.2% | 0.01% | +30.0% |
Q4 2015 | $1,726,000 | – | 341,725 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |